#nvo — Public Fediverse posts

LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case

Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
#NewsBeep #News #Medication #ATTAIN-MAINTAINtrial #CA #Canada #EliLillyandCompany #Foundayo #glp-1 #Health #LLY #NovoNordisk #NVO #oralweightlossmedication #weightlossmaintenance #Zepbound
https://www.newsbeep.com/ca/686827/

LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case

Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
#NewsBeep #News #Medication #ATTAIN-MAINTAINtrial #AU #Australia #EliLillyandCompany #Foundayo #GLP-1 #Health #LLY #NovoNordisk #NVO #oralweightlossmedication #weightlossmaintenance #Zepbound
https://www.newsbeep.com/au/687717/

LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case

Shares of Eli Lilly and Company NYSE: LLY, the world’s most valuable pharmaceutical stock, started 2026 in a…
#NewsBeep #News #Medication #ATTAIN-MAINTAINtrial #AU #Australia #EliLillyandCompany #Foundayo #GLP-1 #Health #LLY #NovoNordisk #NVO #oralweightlossmedication #weightlossmaintenance #Zepbound
https://www.newsbeep.com/au/687717/

https://www.europesays.com/uk/978209/ LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case #ATTAINMAINTAINTrial #EliLillyAndCompany #Foundayo #GLP1 #Health #LLY #Medication #NovoNordisk #NVO #OralWeightLossMedication #UK #UnitedKingdom #WeightLossMaintenance #Zepbound

https://www.europesays.com/ie/497670/ LLY Stock: Foundayo Data Bolsters Weight-Loss Maintenance Case #ATTAINMAINTAINTrial #Éire #EliLillyAndCompany #Foundayo #GLP1 #Health #IE #Ireland #LLY #Medication #NovoNordisk #NVO #OralWeightLossMedication #WeightLossMaintenance #Zepbound

https://www.europesays.com/dk/85300/ 3 Deeply Undervalued Stocks You Can Buy for Less Than $100 Right Now #futures #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #NovoNordisk #NovoNordiskA/SADR #NVO #TheGlobeAndMail

https://www.europesays.com/dk/85206/ Novo Nordisk details latest share buybacks | NVO SEC Filing #6KFiling #BShares #DKK15Billion #NovoNordisk #NVO #ShareBuyback #ShareRepurchase #TreasuryShares

https://www.europesays.com/dk/83362/ Buy, Sell, or Hold Novo Nordisk at $46? #futures #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #NovoNordisk #NovoNordiskA/SADR #NVO #TheGlobeAndMail

https://www.europesays.com/dk/82420/ Novo Nordisk A/S Q1 Earnings Call Highlights #futures #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #NovoNordisk #NovoNordiskA/SADR #NVO #TheGlobeAndMail

https://www.europesays.com/dk/81599/ Novo Nordisk discloses gifted shares to CFO associates | NVO SEC Filing #CFOAssociates #DanishHealthcareCompany #Form6K #GiftedShares #InsiderTransactions #MarketAbuseRegulation #NovoNordisk #NVO

https://www.europesays.com/dk/80780/ HIMS Stock Drops on Q1 Miss as Novo Nordisk GLP-1 Pivot Lifts Costs #GLP1 #Hims #Hims&Hers #NovoNordisk #NVO #ozempic #pharmaceutical #Telehealth #Wegovy #WeightLoss

https://www.europesays.com/dk/78017/ Q1 FY2026 Earnings Preview After FDA Move and NVO Collaboration #CompoundedSemaglutide #GLP1 #HealthcareSector #Hims #Hims&HersHealth #NovoNordisk #NVO #Q12026Earnings #SubscriberGrowth #TelehealthStocks

https://www.europesays.com/dk/77099/ FDA GLP-1 Compounding Proposal Boosts LLY, NVO, and HIMS Stock #EliLilly #FDA503BProposal #GLP1Compounding #Hims #HimsAndHersHealth #LLY #NovoNordisk #NVO #semaglutide #Tirzepatide

https://www.europesays.com/dk/75274/ Novo Nordisk completes DKK 3.8B share buyback | NVO SEC Filing #BShares #DKK15BillionProgramme #Form6K #NovoNordisk #NVO #ShareRepurchase #StockBuyback #TreasuryShares

https://www.europesays.com/dk/69422/ Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing #BShares #DKK15Billion #NasdaqCopenhagen #NovoNordisk #NVO #NYSEADR #ShareRepurchaseProgramme #StockBuyback #TreasuryShares

https://www.europesays.com/dk/64606/ Novo Nordisk’s etavopivat hits phase 3 goals in SCD | NVO SEC Filing #Etavopivat #FastTrackDesignation #HaemoglobinResponse #HIBISCUSTrial #NovoNordisk #NVO #Phase3Results #SickleCellDisease #VasoOcclusiveCrises

https://www.europesays.com/dk/?p=60353 Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing #DKK15Billion #Form6K #InvestorUpdate #NovoNordisk #NVO #ShareBuyback #ShareRepurchaseProgramme #TreasuryShares

https://www.europesays.com/dk/56960/ Novo Nordisk updates DKK 15B share buyback | NVO SEC Filing #BShares #Buyback #DKK15Billion #Form6K #NovoNordisk #NVO #ShareRepurchase #TreasuryShares

https://www.europesays.com/dk/?p=51655 Novo Nordisk updates DKK 15bn share buyback | NVO SEC Filing #BShares #DKK15Billion #NasdaqCopenhagen #NovoNordisk #NVO #NYSE #ShareRepurchase #StockBuyback #TreasuryShares

https://www.europesays.com/dk/50783/ Novo Nordisk AGM approves 2025 dividend, buyback | NVO SEC Filing #AnnualGeneralMeeting #BoardElections #CapitalIncreaseAuthorisation #DeloitteAuditor #Dividend2025 #NovoNordisk #NVO #ShareBuyback

https://www.europesays.com/dk/50778/ Novo Nordisk wins FDA approval for Awiqli insulin | NVO SEC Filing #Awiqli® #DiabetesTreatment #FDAApproval #NovoNordisk #NVO #OnceWeeklyBasalInsulin #ONWARDSPhase3a #Type2Diabetes

https://www.europesays.com/dk/47828/ Novo Nordisk updates 2026 share bu… | NVO SEC Filing #6KFiling #BShares #DKK15Billion #NovoNordisk #NVO #ShareRepurchase #StockBuyback #TreasuryShares

https://www.europesays.com/dk/45337/ Novo Nordisk wins FDA approval for Wegovy HD | NVO SEC Filing #FDAApproval #NovoNordisk #NVO #ObesityTreatment #Semaglutide72Mg #STEPUPTrial #Type2Diabetes #Wegovy®HD #WeightLoss207%

https://www.europesays.com/dk/43903/ Novo Nordisk Receives FDA Approval For Higher Dose Of Its Weight-Loss Drug Wegovy #NovoNordisk #NovoNordiskShares #NovoNordiskStock #NovoNordiskWeightLoss #NVO #NvoShares #NVOStock #Wegovy #Wegovy72Mg #WegovyPrice #Wegovy®HD #WhatIsWegovyHd

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

Last Updated: Feb. 11, 2026 at 8:59 a.m. ETFirst Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled…
#NewsBeep #News #Medication #CA #Canada #consumer-affairs #corporate #Corporate/IndustrialNews #ELILILLY&CO #Health #HealthCare #Hims #Hims&HersHealthInc #industrialnews #LLY #Manufacturing #NovoNordiskA/SADR #NVO #pharmaceuticals
https://www.newsbeep.com/ca/469518/

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled that there’s finally a GLP-1 pill, but swallo…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication ##ConsumerAffairs #corporate #Corporate/IndustrialNews #ELILILLY&CO #Health #Healthcare #hims #Hims&HersHealthInc #industrialnews #LLY #manufacturing #NovoNordiskA/SADR #NVO #Pharmaceuticals
https://www.newsbeep.com/us/461304/

Taking the new Wegovy pill every day is really complicated. Will patients stick with it?

Published: Feb. 10, 2026 at 3:48 p.m. ET Patients are thrilled that there’s finally a GLP-1 pill, but swallo…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication ##ConsumerAffairs #corporate #Corporate/IndustrialNews #ELILILLY&CO #Health #Healthcare #hims #Hims&HersHealthInc #industrialnews #LLY #manufacturing #NovoNordiskA/SADR #NVO #Pharmaceuticals
https://www.newsbeep.com/us/461304/

https://www.europesays.com/ie/330818/ Taking the new Wegovy pill every day is really complicated. Will patients stick with it? #CONSUMERAFFAIRS #Corporate #Corporate/IndustrialNews #Éire #ELILILLY&CO #Health #HealthCare #Hims #Hims&HersHealthInc #IE #IndustrialNews #Ireland #LLY #Manufacturing #Medication #NovoNordiskA/SADR #NVO #pharmaceuticals

$HIMS launching $49 WeGovy knock-off. $NVO -8% pre-market, if it closes here would be the lowest in almost 5 years. www.reuters.com/business/hea...

OOF $NVO

FCF Conversion 💰

Does #EBIT turn into free cash flow?

➡️ #NVO and #RMS convert ~70%.
➡️ #STR and #DSY convert over 100%, a warning sign (!) that needs investigation.

None get a clean pass here!

(3/5)

Allocation Ratios 🔄

How do they spend their cash, reinvest or buy back shares?

➡️ #NVO, #STR and #RMS show inconsistent reinvestment patterns.
➡️ #DSY leans heavily toward buybacks.

Mixed signals across the board!

(2/5)

Cash Is Truth 💵

#Revenue tells a story, but cash delivers the reality check.

Today’s sneak peek looks at how #NVO, #STR, #RMS and #DSY actually turn profits into cash.

Let’s dig in!

(1/5)

#ValueInvesting #Investing #Finance #FinancialAnalysis #Markets

Cash Is Truth 💵

#Revenue tells a story, but cash delivers the reality check.

Today’s sneak peek looks at how #NVO, #STR, #RMS and #DSY actually turn profits into cash.

Let’s dig in!

(1/5)

#ValueInvesting #Investing #Finance #FinancialAnalysis #Markets

Working Capital Quality 📊

Does #revenue convert to #cash?

☑️ #STR, #RMS and #DSY pass.
☑️ #NVO gets a red flag, but not for the reason you think.

More in the full Validation series!

(5/5)

#FindItFinancials #TheBarnBlog #NotInvestmentAdvice

Working Capital Quality 📊

Does #revenue convert to #cash?

☑️ #STR, #RMS and #DSY pass.
☑️ #NVO gets a red flag, but not for the reason you think.

More in the full Validation series!

(5/5)

#FindItFinancials #TheBarnBlog #NotInvestmentAdvice

Net Debt / OCF 💰

How exposed are they to #debt?

🟢 Below 2.0x = strong
🟡 2–4x = manageable
🔴 Above 4x = red flag

#NVO, #STR, #RMS and #DSY all land safely below 2.0x -> green light!

(2/5)

Validation Sneak Peek 🔎

This week we start the balance-sheet reality check in #TheBarnBlog

Four cornerstone metrics reveal how resilient our screener finalists really are.

Let’s see what #NVO, #STR, #RMS and #DSY look like!

(1/5)

#FindItFinancials #ValueInvesting #FinancialAnalysis #Markets

Validation Sneak Peek 🔎

This week we start the balance-sheet reality check in #TheBarnBlog

Four cornerstone metrics reveal how resilient our screener finalists really are.

Let’s see what #NVO, #STR, #RMS and #DSY look like!

(1/5)

#FindItFinancials #ValueInvesting #FinancialAnalysis #Markets

​$11.7B ICFR GAP. Pothole? No. Structural failure.

​Novo Nordisk’s manufacturing scale-up strategy is built on a #CriticalRisk: The Catalent acquisition systems are excluded from ICFR oversight.

​They solved for supply. They failed on data integrity.

​A hostile data strategist targets this control gap.

​Find your competitor's fatal flaw: Data-Backed Competitive Insight. $6k.

​#DataGovernance #MAndA #NVO #ShaolinDataScience

​$11.7B ICFR GAP. Pothole? No. Structural failure.

​Novo Nordisk’s manufacturing scale-up strategy is built on a #CriticalRisk: The Catalent acquisition systems are excluded from ICFR oversight.

​They solved for supply. They failed on data integrity.

​A hostile data strategist targets this control gap.

​Find your competitor's fatal flaw: Data-Backed Competitive Insight. $6k.

​#DataGovernance #MAndA #NVO #ShaolinDataScience

Novo Nordisk stock is down 3.77% today, and pre-market action saw a shocking 19% drop. Analysts are split: panic or potential?
👉 Read: https://allnewtrending.com/novo-nordisk-stock-takes-a-hit/

#NovoNordisk #StockNews #Biotech #Investing #NVO

Nvoi ( #NVO ) has released " Q1 Management's Discussion and Analysis " on Wed 07 May at 08:23 AEST #tax #government #Pilbara #trading #Mining
https://grafa.com/asset/novo-resources-corp-22314-nvo.asx?utm_source=asxmktsensitive&utm_medium=mastodon&utm_campaign=nvo.asx

Är börsen öppen idag?

Ja det är den. Kul då kan vi handla aktier igen. Novo Nordisk sticker uppåt efter sin kraftiga dipp.
Köpte ni i dippen?

#börs #aktie #NovoNordisk #nvo

Idag handlades Novo Nordisk till vrakpris. Bra köptillfälle så här inför jul.

Mellandagsrean började tidigt skulle man kunna säga. En rejäl prissänkning på 20%.

#aktier #mellandagsrea #börs #nvo

“Nevalstiskās organizācijas nav dienests”
– Inese Vaivare stāsta par biedrību iesaisti civilajā aizsardzībā Ministru kabineta Zaļajā zālē.
#nvo

@dysletkiker @Investgbg

Based on my reading, I can provide insights on various stocks, explaining the markets they operate in and why they may or may not be a good buy. For instance, I believe in #NVO (Novo Nordisk) and #LLY (Eli Lilly) due to my reading.

@dysletkiker @Investgbg

Based on my reading, I can provide insights on various stocks, explaining the markets they operate in and why they may or may not be a good buy. For instance, I believe in #NVO (Novo Nordisk) and #LLY (Eli Lilly) due to my reading.

@dysletkiker @Investgbg

Based on my reading, I can provide insights on various stocks, explaining the markets they operate in and why they may or may not be a good buy. For instance, I believe in #NVO (Novo Nordisk) and #LLY (Eli Lilly) due to my reading.